HomePartnerships...Scientific Advisory Board PEPFAR

# Scientific Advisory Board PEPFAR

As PEPFAR continues to accelerate progress toward achieving HIV/AIDS epidemic control, we receive advice from a broad array of experts on our Scientific Advisory Board (SAB) that helps inform our priorities, direction, strategies, and how best to weigh risks and benefits. SAB members represent the diversity of stakeholders in the global HIV/AIDS community, including representatives from academia, partner governments, multilateral and bilateral institutions, foundations, advocates, faith leaders, and non-governmental organizations.

The SAB is a federal advisory committee meeting the standards and regulations of the Federal Advisory Committee Act. The Board acts in a solely advisory capacity, concerning scientific, implementation, and policy issues related to the global response to HIV/AIDS. These issues are of ongoing concern and serve to maximize the impact of our investments toward controlling and ultimately ending the HIV/AIDS epidemic.

For more information on the PEPFAR SAB, see below:
        - SAB Members
        - PEPFAR SAB Meeting Notes – April 5, 2024
        - PEPFAR SAB Meeting Full Recording – April 5, 2024
        - Agenda for PEPFAR’s Scientific Advisory Board Meeting - April 5, 2024
        - Agenda for PEPFAR’s Scientific Advisory Board Meeting – October 2nd
        - PEPFAR SAB Meeting Notes – October 2, 2023
        - PEPFAR SAB Meeting Full Recording – October 2, 2023
        - SAB recommendations – June and September 2022 [213 KB]
        - PEPFAR SAB Meeting Full Recording – September 8, 2022 (YouTube)
        - PEPFAR SAB Meeting Full Transcript – September 8, 2022 [916 KB]
        - PEPFAR SAB Meeting Agenda – September 8, 2022  [159 KB]
        - Recent Infection Surveillance – September 8, 2022 [3 MB]
        - Recency Testing in PEPFAR – September 8, 2022 [3 MB]
        - Considerations for PEPFAR on the Implementation of HIV-1 Recent Infection Surveillance An Implementing Partner’s Perspective – September 8, 2022 [1 MB]
        - Technical Guidance on the Use of Recency Assays for HIV Surveillance – September 7, 2022 [635 KB]
        - Impact and Cost-Effectiveness of HIV Recency Testing – September 8, 2022 [1,005 KB]
        - PrEP Ring: Procurement and Price [139 KB]
        - Dapivirine Vaginal Ring for HIV Prevention Technical Considerations and Regulatory Landscape [3 MB]
        - Reimaging PEPFAR and Partnering Toward Sustained HIV Impact – High-Level Strategic Direction [5 MB]
        - PEPFAR SAB September 2022 Meeting Agenda and Connection Information – September 8, 2022 [136 KB]
        - PEPFAR SAB Meeting Full Recording – June 7, 2022 (YouTube)
        - PEPFAR SAB Meeting – Injectable CAB for PrEP – June 7, 2022 [681 KB]
        - PEPFAR SAB Meeting – Recent Infection Monitoring Presentation – June 7, 2022 [9 MB]
        - PEPFAR SAB Meeting Summary – June 7, 2022 [154 KB]
        - PEPFAR SAB Meeting Transcript – June 7, 2022 [271 KB]
        - PEPFAR SAB Meeting Agenda – June 7, 2022 [222 KB]
        - PEPFAR SAB Meeting Information June 7, 2022 [211 KB]
        - PEPFAR SAB November 2021 Meeting Agenda
        - PEPFAR SAB October 2020 Meeting Agenda [206 KB]  &  Summary [145 KB]
        - PEPFAR SAB October 2019 Meeting [273 KB]
        - People and Planning for Success Success for PEFAR SAB Oct 2019 [2 MB]
        - DTG update SAB Oct 2019 [2 MB]
        - PEPFAR Weight gain Oct 19 [1 MB]
        - Recency Testing Recommendations [129 KB]
        - UTT Discussion Slides [961 KB]
        - Materials from Past Meetings

Back to Top